QBI Highlights

A new study reveals how HIV-infected immune cells can reprogram cervical tissue and activate pathways linked to cancer progression

A former ARPA-H leader and global health expert brings experience in translational science, technology innovation, and pandemic preparedness to help advance QBI’s mission and technology strategy.

A New Study Reveals How Protein-to-Protein Interaction Mapping Decodes the Molecular Origins of Pandemic Viruses

A veteran leader in pharma, infectious disease, and global health joins QBI to help accelerate the translation of PPI science into therapeutic impact and industry partnerships.

Researchers at QBI, UCSF, and Gladstone Institutes published a new Cell study delivering a comprehensive map of how HIV interacts with human proteins in primary immune cells.

On March 16, 2016, UCSF announced the establishment of the Quantitative Biosciences Institute, with a mission to connect researchers across disciplines and advance understanding of disease biology.

In recognition of International Women’s Day, QBI reflects on its ongoing commitment to supporting women’s talent, leadership, and discovery across the scientific community.

Leah Roe joined QBI as a Fellow, becoming part of a program that supports early-career scientists in launching independent research within UCSF’s collaborative environment.

Explore our 2025 timeline to celebrate the people, projects, and moments that shaped the year.

The agreement launches a cross-border partnership at the intersection of AI and biomedical research.

QBI welcomed Kevin Lou to our Fellowship Program, designed to support early-career scientists in launching independent research within UCSF’s collaborative environment.

QBI introduced a series highlighting our scientists’ curiosity, challenges, and hopes, debuting with a cancer-focused edition in honor of Cancer Awareness Month.